GPT and metabolic dysfunction-associated steatotic liver disease: The qualitative appraisal revealed that the probiotic-supplemented NAFLD rodents were presented with reduced serum ALP (n = 4/6) (Figure 3A), with mixed outcomes on serum ALT (reduced; n = 25/52, no changes; n = 26/52, increased; n = 1/52), and with no changes on serum AST (n = 27/38).